THEMISMED NSE filing

Themis Medicare Submits Valuation Report for Preferential Allotment of Warrants

The RealCase readLow impact Neutral

Themis Medicare Limited submitted a valuation report and updated compliance certificate for preferential allotment of convertible warrants. This follows Board approval on February 13, 2026, and addresses queries from stock exchanges.

Why it matters

The announcement pertains to a procedural step in a preferential allotment process, which is a standard corporate action and does not immediately impact the company's financials or operations significantly.

The market read

The announcement is a routine regulatory filing regarding a preferential allotment process and does not contain explicit positive or negative financial news.

Themis Medicare Limited has submitted a Valuation Report from an Independent Registered Valuer and an updated Compliance Certificate from a Practicing Company Secretary to BSE Limited and the National Stock Exchange of India Limited. These submissions are in relation to the company's application for preferential allotment of convertible warrants, which received approval from the Board of Directors on February 13, 2026.

The Valuation Report can be accessed at: https://www.themismedicare.com/uploads/statutory/pdf/Annexure%201_Valuation%20Report%20-%20TML.pdf

The updated Practicing Company Secretary Certificate is available at: https://www.themismedicare.com/uploads/statutory/pdf/Revised%20Compliance%20Certificate%20Themis%20Pref%20Issue%2023042026.pdf

This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Filing to action

What to do with a filing like this

Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.

View original filing